Dr. Heiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Rm 5D37
Bethesda, MD 20892Phone+1 301-496-2921Fax+1 301-402-0380
Education & Training
- NIH Clinical Center1991 - 1994
- University of Cincinnati Medical Center/College of MedicineResidency, Neurological Surgery, 1980 - 1987
- University of Michigan Medical SchoolClass of 1980
- University of MichiganB.S., Biomedical Sciences, 1974 - 1977
Certifications & Licensure
- MD State Medical License 1999 - 2026
- OH State Medical License 1981 - 2026
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- NIH Director’s Award Niemann-Pick Disease, type C, Therapeutic Development Team, 2013
- Excellence in Technology Transfer Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), 2012
- Special Recognition Award, for “exemplary performance while demonstrating significant leadership, skill, and ability in serving as a mentor.” NINDS, 2010
- Join now to see all
Clinical Trials
- Genetic Analysis of the Chiari I Malformation Start of enrollment: 2001 Jun 04
- Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease Start of enrollment: 2001 Feb 15
- Brain Infusion of Muscimol to Treat Epilepsy Start of enrollment: 2000 Jun 23
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsPharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade.Winson S. Ho, Herui Wang, Dominic Maggio, John S. Kovach, Qi Zhang
Nature Communications. 2018-05-29 - 14 citationsThe post–syrinx syndrome: stable central myelopathy and collapsed or absent syrinxEnver I. Bogdanov, John D. Heiss, E. G. Mendelevich
Journal of Neurology. 2006-03-06 - 2 citationsThe epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses.Christian K Ramsoomair, Michele Ceccarelli, John D Heiss, Ashish H Shah
Journal of Translational Medicine. 2023-12-09
Journal Articles
- “Hidden” bone metatstasis from thyroid carcinoma: a clinical note.Sioka C, Skarulis MC, Tulloch-Reid MK, Heiss JD, Reynolds JC, Rev Esp Med Nucl Imagen Mol, Published Online July 8, 2013, 1/1/2013
- Rapidly progressive monoparesis caused by Chiari malformation type 1 without syringomyelia.Oishi M, Hayashi Y, Kita D, Fukui I, Shinohara M, Heiss JD, Hamada, J. Surgical Neurology Int, Published Online June 12, 2013, 1/1/2013
- Normalization of hindbrain morphology after decompression of Chiari malformation Type 1.Heiss JD, Suffredini G, Bakhtian KD, Sarntinoranont M, Oldfield EH, J Neurosurg, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Method to Record, Store, and Analyze Multiple Physiologic Pressure Recordings.Sansur C, Eidsath A, DeVroom H, Heiss JD, The 14th IEEE Symposium on Computer-Based Medical Systems, Bethesda, MD, 7/1/2001
Lectures
- Which Patients with Chiari Malformation7/1/2013
- Pathophysiology of Syringomyelia, International Guest Speaker,Kazan, Tartar Republic, Russia - 6/1/2013
- AAV2-GDNF Clinical Trial for Parkinson’s Disease.NINDS, NIH - 6/1/2013
- Join now to see all
Professional Memberships
- Fellow
- Member
- Society for Brain Mapping and TherapeuticsBoard of Directors Ex Officio Member
- Mayfield SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: